Big Pharma companies have built empires out of human pain without managing to come close to addressing the number one cause of disability in the world: Depression, a disease that costs the economy a trillion dollars in lost production every year.
But while Big Pharma is turning over billions in...
The market's feel-good rally has hit a wall of worry. After weeks of defying gravity, stocks are starting to crack under the strain of stubborn inflation, rising yields, and a looming wave of Big Tech earnings.
This week could be a pivotal moment. Critical economic data will either soothe investor...
Helium is used to cool magnets in MRI machines.
When we think of helium, perhaps the first thing that comes to mind is birthday balloons, but the applications for this gas go much deeper. And the demand for helium is increasing year over year.
In 2023, the Helium Market is projected...
Thousands of years ago, ancient Aztecs may have held the key to the next biotech breakthrough.
During ceremonial rituals, they used a special compound they called “the flesh of the gods”...
And today, researchers are discovering that this same compound could transform how we approach mental health moving forward…
Sparking an explosion...
The End of Just-In-Time Manufacturing as we Know It
Just-in-time (JIT) manufacturing was initiated in the 1950s and 1960s by Toyota. The approach was developed as part of the Toyota Production System (TPS), which aimed to minimize waste and improve efficiency in manufacturing processes.
The concept of JIT revolves around producing...
Nine months of patience may finally pay off for investors
After nine months of relative quiet, the Federal Reserve might finally be ready to pull the trigger on a rate cut this September. Investors have already started pricing in an 85% chance of a 25 basis point reduction, and history...
As the curtain closes on the stock market’s acclaimed ‘good’ season, we stand at the crossroads of profit and prudence. With portfolios plumped up like Thanksgiving turkeys, thanks to a 22% feast since November, the temptation to pocket those gains and saunter into summer is palpable.
But before you decide...
Bitcoin's been on a rollercoaster this year, and it seems like the ride's not over yet. We've seen record highs, whispers of regulation, and a crypto world constantly reinventing itself. In this week's edition of The Market Pulse, we're looking at the four catalysts that could catapult Bitcoin to...
For people suffering from myasthenia gravis (mg) and other debilitating autoimmune disorders, daily life can be miserable. Patients suffering from mg complain about extreme muscle weakness and fatigue, which can make routine activities like chewing and swallowing very difficult to accomplish.
Immunovant (NASDAQ: IMVT) just reported after early-stage data from...
